Recombinant Grapevine leafroll-associated virus 3 Protein P7 (ORF12)

Shipped with Ice Packs
In Stock

Description

Genetic Context and Variability

ORF12 resides in the 3′-proximal unique gene block (UGB) of the GLRaV-3 genome, which exhibits high genetic variability compared to conserved regions like the replication gene block . Key findings include:

  • Low inter-group variability: ORF12 shows 6.0–17.4% nucleotide divergence among GLRaV-3 groups I–IV but higher divergence (28.3–38.7%) in group VI isolates .

  • Contrast with ORF11: Unlike ORF11 (which shows 68–86% amino acid divergence), ORF12 is more conserved, suggesting potential functional constraints despite lacking homology to other Closteroviridae proteins .

Functional Insights

The biological role of ORF12 remains poorly characterized:

  • Non-essential for replication: ORF12 is absent in other Closteroviridae members and shows no conserved motifs, implying a niche or host-specific function .

  • Hypothetical roles: Proposed involvement in viral movement or host-pathogen interactions, though experimental validation is lacking .

  • Transcriptional regulation: ORF12 is expressed via a subgenomic RNA (sgRNA), but its sgRNA abundance is lower than those of ORFs 6, 8, 9, and 10 .

Diagnostic Assays

Recombinant P7 is used in ELISA kits for high-throughput screening of GLRaV-3 infections, offering specificity for antibody detection .

Limitations

  • No peer-reviewed studies directly link P7 to RNA silencing suppression or viral pathogenicity, unlike GLRaV-3 ORF10 (p20B) .

  • Commercial availability is limited to research-grade products .

Future Directions

While ORF12’s function remains enigmatic, its conserved sequence in key GLRaV-3 variants warrants further study. Priorities include:

  • Interaction screens: Identify host proteins binding to P7 using yeast two-hybrid or Co-IP assays.

  • Knockout studies: Use infectious cDNA clones to assess ORF12’s impact on viral replication .

Product Specs

Form
Lyophilized powder.
Note: While we prioritize shipping the format currently in stock, please specify your preferred format in order notes for fulfillment.
Lead Time
Delivery times vary depending on the purchasing method and location. Contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless dry ice is specifically requested in advance. Additional fees apply for dry ice shipments.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and serves as a guideline.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer components, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is finalized during production. To request a specific tag, please inform us, and we will prioritize its development.
Synonyms
ORF12; Protein P7; 7 kDa protein
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-60
Protein Length
full length protein
Species
Grapevine leafroll-associated virus 3 (isolate United States/NY1) (GLRaV-3) (Grapevine leafroll-associated closterovirus (isolate 109))
Target Names
ORF12
Target Protein Sequence
MRHLEKPIRVAVHYCVVRSDVCDGWDVFIGVTLIGMFISYYLYALISICRKGEGLTTSNG
Uniprot No.

Target Background

Database Links

KEGG: vg:1444475

Subcellular Location
Host membrane; Single-pass membrane protein.

Q&A

What is GLRaV-3 Protein P7 (ORF12) and how does it differ from other viral proteins?

P7 (ORF12) is a small 7 kDa protein that is unique to GLRaV-3 and not present in other members of the Closteroviridae family. The protein consists of 60 amino acids with the sequence: MRHLEKPIRVAVHYCVVRSDVCDGWDVFIGVTLIGMFISYYLYALISICRKGEGLTTSNG. While many viral proteins have conserved functions across related viruses, P7 appears to be distinctive to GLRaV-3, suggesting a potentially specialized role in its viral lifecycle or host interactions .

What expression systems have been successfully used for recombinant P7 production?

The most documented expression system for P7 is bacterial expression using E. coli, where the protein is typically fused with an N-terminal His-tag to facilitate purification. This system allows for reasonable protein yields suitable for initial characterization studies. The small size of P7 makes it amenable to bacterial expression, though researchers should be aware that post-translational modifications that might occur in the plant host would be absent. Alternative expression systems such as insect cells or plant-based expression systems may provide protein with more native-like characteristics, but these approaches are less well-documented for this specific protein .

What are the methodological challenges in isolating and purifying recombinant P7 protein?

The primary challenges include:

  • Protein stability: The small size and potentially hydrophobic nature of P7 can lead to aggregation issues

  • Yield optimization: Buffer composition significantly affects yield

  • Maintaining native structure: Ensuring the recombinant version maintains functionality

Recommended purification protocol includes:

  • Immobilized metal affinity chromatography (IMAC) using the His-tag

  • Careful buffer selection (typically Tris/PBS-based with 6% trehalose, pH 8.0)

  • Storage with 5-50% glycerol to prevent freeze-thaw degradation

  • Avoiding repeated freeze-thaw cycles and storing working aliquots at 4°C for short-term use

What experimental approaches are recommended for investigating the function of P7 in the viral lifecycle?

Given the limited knowledge about P7's function, a multi-faceted approach is recommended:

  • Yeast two-hybrid or co-immunoprecipitation assays: To identify potential protein interactions with host or other viral proteins

  • In planta expression studies: Using transient expression systems to observe cellular localization and phenotypic effects

  • Reverse genetics: Creating GLRaV-3 mutants with modified or deleted ORF12 using infectious cDNA clones where available

  • Comparative transcriptomics: Analyzing host gene expression changes in response to P7 expression alone versus complete virus infection

This combined approach may help elucidate whether P7 functions in viral replication, movement, suppression of host defenses, or other aspects of the viral lifecycle .

How does P7 potentially contribute to viral pathogenicity or host interactions?

While direct evidence is limited, investigation pathways should consider:

  • Membrane association analyses: The hydrophobic regions in P7 suggest potential interactions with cellular membranes that might facilitate viral replication complex formation

  • Host defense suppression assays: Testing if P7 interferes with RNA silencing pathways, similar to other viral proteins

  • Proteomic studies: Identifying host proteins that interact with P7 during infection

Unlike some other GLRaV-3 proteins, P7 has not been definitively linked to RNA silencing suppression or other specific pathogenicity functions, making it an intriguing target for novel function discovery .

How does evolutionary analysis of P7 compare across different GLRaV-3 variants?

Three major genetic variants of GLRaV-3 have been identified in vineyards worldwide, with significant sequence variability. Comparative analysis of P7 across these variants would be valuable to:

  • Determine conservation levels of specific amino acid residues

  • Identify potential adaptation signatures related to host specificity

  • Evaluate selective pressure on this unique protein through dN/dS ratio analysis

The high variability observed in the 5'UTR of different variants (up to 33% between groups) suggests that non-essential genes like ORF12 might also display significant variability, potentially reflecting adaptation to different hosts or vectors .

What can comparative genomics tell us about the origin and significance of P7 in GLRaV-3?

Since P7 (ORF12) is unique to GLRaV-3 and absent in related viruses, comparative genomics approaches can help understand:

  • Whether P7 arose through gene duplication, horizontal gene transfer, or de novo gene emergence

  • If P7 provides selective advantages in certain host cultivars or environments

  • Whether the protein is under purifying or diversifying selection

The unique nature of this protein compared to other members of Closteroviridae suggests it may have emerged relatively recently in evolutionary terms, potentially providing GLRaV-3 with specific adaptive advantages in grapevine hosts .

What role might P7 play in the characteristic symptomatology of grapevine leafroll disease?

A systematic approach to investigating P7's potential role in symptom development would include:

  • Transgenic expression: Developing transgenic grapevines expressing only P7 to observe any phenotypic effects

  • Metabolomic analysis: Comparing metabolite profiles between healthy plants, P7-expressing plants, and GLRaV-3 infected plants

  • Histological studies: Examining cellular changes in phloem tissues of P7-expressing plants

  • Photosynthetic efficiency measurements: Determining if P7 alone affects photosynthetic machinery

Current evidence suggests that the characteristic symptoms of leaf discoloration and downward rolling likely result from complex interactions of multiple viral proteins with host physiology, but the specific contribution of P7 remains undetermined .

What cutting-edge methodologies could advance our understanding of P7 structure-function relationships?

Several advanced techniques could significantly enhance our understanding:

MethodologyApplication to P7 ResearchExpected Outcomes
Cryo-electron microscopyStructural determination at near-atomic resolutionDetailed 3D structure revealing functional domains
Hydrogen-deuterium exchange mass spectrometryIdentification of solvent-exposed regionsInsights into protein dynamics and interaction surfaces
Single-molecule FRETReal-time monitoring of P7 interactions with potential partnersKinetic and conformational data on binding events
AlphaFold2 or similar AI prediction toolsComputational structure predictionInitial structural models to guide experimental design
CRISPR-based viral evolution trackingMonitoring P7 sequence changes during host adaptationUnderstanding of selective pressures on P7 during infections

These approaches would help bridge the significant knowledge gap regarding this enigmatic viral protein .

What controls are essential when studying recombinant P7 protein in experimental systems?

Rigorous experimental design requires several controls:

  • Empty vector controls: When expressing P7 in any system, parallel experiments with empty vector are essential

  • Tag-only protein controls: Since P7 is often expressed with tags, a tag-only protein should be included to rule out tag-specific effects

  • Denatured protein controls: To distinguish between structure-dependent and structure-independent effects

  • Related viral protein controls: Including proteins from other GLRaVs to identify GLRaV-3-specific effects

Additionally, researchers should validate protein expression and localization using both Western blotting and immunofluorescence microscopy to ensure the recombinant protein is correctly expressed and localized .

How can researchers optimize protocols for studying P7-host protein interactions?

Optimizing protein interaction studies for P7 requires consideration of:

  • Buffer composition: The hydrophobic nature of P7 necessitates careful buffer optimization to maintain solubility while preserving native interactions

  • Cross-linking approaches: Transient interactions may require chemical cross-linking prior to pulldown experiments

  • Detergent selection: Membrane-associated interactions may require mild detergents that maintain protein structure

  • In planta verification: Confirming interactions observed in vitro with in planta approaches such as bimolecular fluorescence complementation

A systematic approach testing multiple conditions is recommended, as the unique nature of P7 means that standard protocols may require significant adaptation .

How does research on P7 complement studies of other GLRaV-3 proteins?

Research on P7 should be integrated with broader GLRaV-3 studies to:

  • Determine potential interactions between P7 and other viral proteins

  • Investigate coordinated expression patterns during infection progression

  • Evaluate the temporal dynamics of P7 expression relative to key infection stages

  • Assess whether P7 functions independently or as part of viral protein complexes

The development of infectious cDNA clones for GLRaV-3 represents an important advancement that could facilitate the study of P7 in the context of the complete viral genome, allowing for targeted mutations and functional analysis in authentic infection scenarios .

What insights might P7 research provide for developing disease resistance strategies?

Understanding P7 could contribute to disease management through:

  • Identification of potential antiviral targets: If P7 serves an essential function, it could represent a novel target for antiviral development

  • Engineering of resistance mechanisms: Knowledge of P7-host interactions might reveal vulnerabilities that could be exploited for resistance

  • Diagnostic applications: P7-specific antibodies or nucleic acid detection methods could enhance virus detection specificity

  • Cross-protection approaches: Modified P7 variants might interfere with wild-type virus infection

As grapevine leafroll disease causes significant economic losses worldwide, expanded research on all viral components, including the unique P7 protein, is warranted to develop comprehensive management strategies .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.